A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation

A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Comparing the Efficacy and Safety of Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) for Triggering of Final Follicular Maturation in Women Undergoing Controlled Ovarian Stimulation

This trial is investigating the efficacy and safety of highly purified human chorionic gonadotropin (HP-hCG) and recombinant human chorionic gonadotropin (rhCG) for triggering of final follicular maturation in women undergoing controlled ovarian stimulation

Inclusion Criteria:

• Pre-menopausal females between the ages of 18 and 39 years
• Documented history of infertility
• Body mass index (BMI) between 17.5 and 32.0 kg/m2
• Regular menstrual cycles

Exclusion Criteria:

• Known endometriosis stage III and IV
• Known polycystic ovarian syndrome (PCOS)
• History of recurrent miscarriage
• History of more than three previous controlled ovarian stimulation cycles